Rising Biosciences (Rising Biosciences) General and Admin. Expense : $ Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Rising Biosciences's General and Admin. Expense for the three months ended in . 20 was $0.00 Mil. Rising Biosciences does not have enough years/quarters to calculate the General and Admin. Expense for the trailing twelve months (TTM) ended in . 20.

Rising Biosciences General and Admin. Expense Historical Data

The historical data trend for Rising Biosciences's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences General and Admin. Expense Chart

Rising Biosciences Annual Data

Trend

General and Admin. Expense

Rising Biosciences Quarterly Data

General and Admin. Expense

Rising Biosciences General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

Rising Biosciences General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » General and Admin. Expense

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.